A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life
Open Access
- 7 June 2021
- journal article
- research article
- Published by SNF Swedish Nutrition Foundation in Food & Nutrition Research
Abstract
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem illness without a currently recognized pharmacological treatment. Dietary supplementation and modification have been posited as potential management strategies; however, their efficacy is controversial. Objective: This study aimed to assess the nutritional intake and supplement use of Australian ME/CFS patients and the perceived effect on health-related quality of life (HRQoL) for the first time in an Australian patient population. Design: Between February 2019 and January 2020, ME/CFS patients across Australia volunteered in this cross-sectional study in response to online advertisements. Eligible respondents were invited to complete three online self-administered questionnaires investigating their supplement use, nutritional intake, and HRQoL. The study participants’ supplement use and nutritional intake were summarized and compared with the population data returned from the Australian Health Survey (2011–2012). Multiple linear regression analysis was also performed to determine the effect of participants’ supplement use and nutrient intake on HRQoL. Results: Twenty-four eligible ME/CFS patients (54.2% meeting the International Consensus Criteria, 79.2% female, mean age = 43.4 ± 10.5 years) completed the online questionnaires. Supplement use was highly prevalent among the study sample (87.5%) and considerably more common when compared with population data (31.9%). Daily total fats and caffeine intakes were significantly higher among ME/CFS patients when compared with the Australian population (P = 0.009 and P = 0.033, respectively), whereas daily intakes of total carbohydrates and alcohol were significantly lower (both P < 0.001). No consistent trends between nutrition and supplement use with patients’ HRQoL could be identified. Conclusions: The daily diet and supplement use of ME/CFS patients appear to vary considerably from those of the general Australian population. Although the role of nutritional intake and supplement use on ME/CFS patients’ HRQoL remains unclear, dietary changes and the use of supplements appear to be of value to ME/CFS patients.Keywords
This publication has 58 references indexed in Scilit:
- Contrasting Case Definitions for Chronic Fatigue Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Myalgic EncephalomyelitisEvaluation & the Health Professions, 2011
- Myalgic encephalomyelitis: International Consensus CriteriaJournal of Internal Medicine, 2011
- The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carersBMC Public Health, 2011
- High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndromeNutrition Journal, 2010
- Alternative Medical Interventions Used in the Treatment and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and FibromyalgiaThe Journal of Alternative and Complementary Medicine, 2010
- Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in GeorgiaHealth and Quality of Life Outcomes, 2009
- The lifestyle of patients with chronic fatigue syndrome and the effect on fatigue and functional impairmentsJournal of Human Nutrition and Dietetics, 2009
- Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome)Journal of Clinical Pathology, 2006
- Myalgic Encephalomyelitis/Chronic Fatigue SyndromeJournal of Chronic Fatigue Syndrome, 2003
- Unproven diet therapies in the treatment of the chronic fatigue syndromeArchives of Family Medicine, 1993